Navigation Links
Developer Of Vaccine For Cancer Granted A Prestigious Fellowship

Researcher, Professor Ian Frazer of the University of Queensland (UQ), has been awarded the Smart State Premier's Fellowship. The prestigious Fellowship comes on top// of his recent Australian of the Year award for his work in developing a vaccine for cervical cancer. Under the Smart State Premier's Fellowship, Professor Ian Frazer will get $250,000 a year for the next five years for his UQ Centre for Immunology and Cancer Research at Brisbane’s Princess Alexandra Hospital. Professor Frazer said the money would help further the development of therapeutic vaccines.

The Smart State Premier's Fellowships provide funding to entice experienced and distinguished researchers of national and international prominence to lead research teams in Queensland universities, research institutes, government agencies or industry research facilities.

Prof Frazer said on ABC Radio, that though The Australian of the Year is a great honour but it is very much an honorary title, and now this fellowship will help him to build up his team and get new initiatives going in the way of research, specifically towards the vaccines that they have been striving to get for the last few years.

Deputy Premier, Treasurer and Minister for State Development, Trade and Innovation Anna Bligh announced the funding today who was in Chicago as part of a trade mission. Stating that the Professor Frazer has put Queensland on the map with his ground breaking scientific achievements. She said that the fellowship money would help Prof Frazer translate the success of the cervical cancer vaccine to other cancers and infections.

The professor has been researching the cause of cervical cancer for the past 20 years and has proven the link between cervical cancers and the papilloma virus. He has also developed the world's first vaccine for cervical cancer. This cancer alone kills 270,000 women each year

Page: 1

Related medicine news :

1. Male Contraception: Discovery Stirring Interest Among Scientists, Drug Developers
2. Vaccine to quit smoking?
3. First Vaccine Designed for Africa Cleared for Testing in Humans
4. Vaccine for Alzheimer’s diseas
5. Health Officials Recommend Flu Vaccine
6. Smallpox Vaccine May Help Fight Cervical Cancer
7. Panacea Biotech To Market Anthrax Vaccine
8. New Prostate Cancer Vaccine Shows Promise
9. Drug Firm Offers to Donate Smallpox Vaccine
10. Vaccine guards against shingles
11. Vaccine for septic conditions
Post Your Comments:

(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... Forecast to 2022" report to their offering. ... date financial data derived from varied research sources to present ... impact on the market during the next five years, including ... sub markets, regional and country level analysis. The report provides ...
Breaking Medicine Technology: